Skip to main content
logo
CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
64.45
-4.19 (-6.10%)
Mar 18, 2026, 4:00 PM EDT - Market closed

CG Oncology Revenue

In the year 2025, CG Oncology had annual revenue of $4.04M with 254.70% growth. CG Oncology had revenue of $2.32M in the quarter ending December 31, 2025, with 409.21% growth.

Revenue (ttm)
$4.04M
Revenue Growth
+254.70%
P/S Ratio
1,346.99
Revenue / Employee
$28,451
Employees
142
Market Cap
5.44B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.04M2.90M254.70%
Dec 31, 20241.14M935.00K458.33%
Dec 31, 2023204.00K13.00K6.81%
Dec 31, 2022191.00K-10.17M-98.16%
Dec 31, 202110.36M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
PTC Therapeutics1.73B
Caris Life Sciences812.03M
Mirum Pharmaceuticals521.31M
Rhythm Pharmaceuticals189.76M
Protagonist Therapeutics46.02M
Kymera Therapeutics39.21M
Xenon Pharmaceuticals7.50M
Revenue Rankings

CGON News

More News